Abdol-Hossein Rezaeian received his Ph.D. at Tokyo University (A&T) and completed his postdoctoral training at the MD Anderson Cancer Center, University of Texas. He is now an Instructor in Pathology at the Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School. Before his current role, he worked at the National Institute for Agro-Environmental Sciences in Japan as a Research Associate (2006–2008), at RIKEN Brain Science Institute, Japan as a Researcher (2009) and at the University of South Carolina as a Research Assitant Professor (2020-2021). He conducts research in Molecular and Cellular Oncology, Cancer Drug Discovery, and the Mechanism of Action (MOA).
Abdol-Hossein Rezaeian received his Ph.D. at Tokyo University (A&T) and completed his postdoctoral training at the MD Anderson Cancer Center, University of Texas. He is now an Instructor in Pathology at the Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School. Before his current role, he worked at the National Institute for Agro-Environmental Sciences in Japan as a Research Associate (2006–2008), at RIKEN Brain Science Institute, Japan as a Researcher (2009) and at the University of South Carolina as a Research Assitant Professor (2020-2021). He conducts research in Molecular and Cellular Oncology, Cancer Drug Discovery, and the Mechanism of Action (MOA).